VOLUME
Buy
TREND
Sell
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Will GNBT stock price go up or down on Tue, 28 May 2019?

Predict

Generex Biotechnology Corp Forecast and Stock Analysis

Technical GNBT stock analysis for Friday May 24, 2019.

Sell candidate since 2019-05-16 Loss -11.40%


Generex Biotechnology Corp fell by -3.80% in the last day ( Friday, 24th May 2019 ) from $1.05 to $1.01 During day the stock fluctuated 5.00% from a day low at $1.00 to a day high of $1.05. The price has fallen in 6 of the last 10 days and is down by -10.62% for this period. Volume has increased in the last day by 40 817 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 53 850 shares bought and sold for approximately $54 388.50.

Quick summary:

  • 30 day high of the GNBT stock price was $1.25 and low was $1.00.
  • 90 day high was $2.05 and low was $1.00.
  • 52 week high for the Generex Biotechnology Corp - $25.30 and low - $0.65.

Trend

Generex Biotechnology Corp lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.46% during the next 3 months and, with 90% probability hold a price between $0.47 and $0.74 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Generex Biotechnology Corp holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.06 and $1.20. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday May 23, 2019, which indicates further falls until a new bottom pivot has been found. Generex Biotechnology Corp gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 35 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $1.01 Resistance: $1.15

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.05 between high and low, or 5.00%. For the last week, the stock has had a daily average volatility of 5.19%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

5.19 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Generex Biotechnology Corp holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Strong Sell Candidate Downgraded

Will GNBT stock price go up or down
on Tue, 28 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank